NSC |
Compound |
Enrichment |
Correlation |
NSC 726365 |
Null |
0.0238174255956147 |
-0.018288511 |
NSC 748382 |
Null |
0.0238174255956147 |
0.046543498 |
NSC 753188 |
4-chloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide |
0.0238174255956147 |
0.2569318 |
NSC 107043 |
Null |
0.024108502230778 |
0.24585118 |
NSC 130279 |
7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 3,4-dihydro-3-.beta.-D-ribofuranosyl- (9CI) |
0.024108502230778 |
-0.10135894 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.024108502230778 |
0.23737537 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.024108502230778 |
-0.13944406 |
NSC 144163 |
Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- |
0.024108502230778 |
0.047544228 |
NSC 626676 |
Null |
0.024108502230778 |
0.22472835 |
NSC 628949 |
Null |
0.024108502230778 |
0.22968006 |